[A fundamental study on T-1982 (cefbuperazone) in the field of obstetrics a gynecology].
T-1982 (cefbuperazone) concentrations in antecubital venous blood and pelvic dead space exudate were examined in 4 patients who had received radical hysterectomy due to uterocervical cancer. Data analysis for the transfer of T-1982 into pelvic dead space exudate was performed with the stimulation curves prepared from pharmacokinetic parameters by the three-compartment model. When T-1982 was given at a dose of 1 g, the peak level in the venous blood was 83.7 micrograms/ml at 1 hour after the start of administration. With regards to T-1982 concentration in pelvic dead space exudate, the peak level of 19.3 micrograms/ml was observed at 2.24 hours after the start of administration and relatively high concentration of about 6.1 micrograms/ml was observed even at 8 hours after the start of administration. From the above results, it is concluded that T-1982 is a useful drug for the treatment of infections in the field of obstetrics and gynecology.
D002513:Cephamycins / Q000378:metabolism*; D005122:Exudates and Transudates / Q000032:analysis; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D010388:Pelvis
D002513:Cephamycins; C035978:cefbuperazone